Literature DB >> 301355

Molecular abnormality of PI S variant of human alpha1-antitrypsin.

A Yoshida, C Ewing, M Wessels, J Lieberman, L Gaidulis.   

Abstract

Alpha1-antitrypsin variant protein was purified to homogeneity from a PI S-S subject with a mild deficiency of plasma trypsin inhibiting capacity. Molecular weight, specific trypsin inhibitory activity, and composition of amino acids and carbohydrates were similar to the proteins purified from Pi M-M individuals with normal alpha1-antitrypsin activity. The structural difference between the normal and the variant alpha1-antitrypsin was elucidated by peptide mapping of their tryptic digests. An amino acid substitution of glutamic acid in the normal protein to valine in the variant protein was found. The result is consistent with the previously reported amino acid substitution in Pi S-Christchurch.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 301355      PMCID: PMC1685311     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  13 in total

1.  The thiobarbituric acid assay of sialic acids.

Authors:  L WARREN
Journal:  J Biol Chem       Date:  1959-08       Impact factor: 5.157

2.  PULMONARY EMPHYSEMA AND ALPHA1-ANTITRYPSIN DEFICIENCY.

Authors:  S ERIKSSON
Journal:  Acta Med Scand       Date:  1964-02

3.  DISC ELECTROPHORESIS. II. METHOD AND APPLICATION TO HUMAN SERUM PROTEINS.

Authors:  B J DAVIS
Journal:  Ann N Y Acad Sci       Date:  1964-12-28       Impact factor: 5.691

4.  STRUCTURAL STUDIES OF AMINOETHYLATED HEMOGLOBINS BY AUTOMATIC PEPTIDE CHROMATOGRAPHY.

Authors:  R T JONES
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1964

5.  Determination of serum glycoproteins.

Authors:  R J WINZLER
Journal:  Methods Biochem Anal       Date:  1955

6.  The spectrophotometric determination of tyrosine and tryptophan in proteins.

Authors:  T W Goodwin; R A Morton
Journal:  Biochem J       Date:  1946       Impact factor: 3.857

7.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

8.  The polymorphism of "prealbumins" and alpha-1-antitrypsin in human sera.

Authors:  M K Fagerhol; C B Laurell
Journal:  Clin Chim Acta       Date:  1967-05       Impact factor: 3.786

9.  Heterozygous and homozygous alpha1-antitrypsin deficiency in patients with pulmonary emphysema.

Authors:  J Lieberman
Journal:  N Engl J Med       Date:  1969-08-07       Impact factor: 91.245

10.  Cirrhosis associated with alpha-1-antitrypsin deficiency: a previously unrecognized inherited disorder.

Authors:  H L Sharp; R A Bridges; W Krivit; E F Freier
Journal:  J Lab Clin Med       Date:  1969-06
View more
  10 in total

1.  Origin of the multiple components of human alpha1-antitrypsin.

Authors:  A Yoshida; M Wessels
Journal:  Biochem Genet       Date:  1978-08       Impact factor: 1.890

Review 2.  Association of alpha 1-antitrypsin deficiency with lung and liver diseases.

Authors:  M Resendes
Journal:  West J Med       Date:  1987-07

3.  A study of restriction fragment length polymorphisms at the human alpha-1-antitrypsin locus.

Authors:  K J Matteson; H Ostrer; A Chakravarti; K H Buetow; W E O'Brien; A L Beaudet; J A Phillips
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

Review 4.  Human gene therapy: present and future.

Authors:  M A Kay; K P Ponder; S L Woo
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

5.  Intrapleural Gene Therapy for Alpha-1 Antitrypsin Deficiency-Related Lung Disease.

Authors:  Katie M Stiles; Dolan Sondhi; Stephen M Kaminsky; Bishnu P De; Jonathan B Rosenberg; Ronald G Crystal
Journal:  Chronic Obstr Pulm Dis       Date:  2018-08-17

6.  Structural difference between the normal PiM1 and the common PiM2 variant of human alpha 1-antitrypsin.

Authors:  A Yoshida; J C Taylor; W G van den Brock
Journal:  Am J Hum Genet       Date:  1979-09       Impact factor: 11.025

7.  An alpha 1-antitrypsin variant, Pi B Alhambra (Lys to Asp, Glu to Asp), with rapid anodal electrophoretic mobility.

Authors:  A Yoshida; R Chillar; J C Taylor
Journal:  Am J Hum Genet       Date:  1979-09       Impact factor: 11.025

Review 8.  Gene Therapy for Alpha-1 Antitrypsin Deficiency Lung Disease.

Authors:  Maria J Chiuchiolo; Ronald G Crystal
Journal:  Ann Am Thorac Soc       Date:  2016-08

9.  Alpha 1-antitrypsin: apparent molecular weight heterogeneity shown by two-dimensional electrophoresis.

Authors:  W T Brown
Journal:  Am J Hum Genet       Date:  1982-03       Impact factor: 11.025

10.  Evaluation of "at risk" alpha 1-antitrypsin genotype SZ with synthetic oligonucleotide gene probes.

Authors:  T Nukiwa; M Brantly; R Garver; L Paul; M Courtney; J P LeCocq; R G Crystal
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.